Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,196
Total Claims
$676K
Drug Cost
681
Beneficiaries
$992
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+21%
Opioid rate vs peers
2.7% vs 2.2% avg
-30%
Cost per patient vs peers
$992 vs $1,411 avg
-5%
Brand preference vs peers
10.1% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.7%
Opioid Rate
277
Opioid Claims
$16K
Opioid Cost
6.9%
Long-Acting Rate
Brand vs Generic
Brand: 1,021 claims · $484K
Generic: 9,103 claims · $189K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 214 | $164K |
| Semaglutide | 32 | $38K |
| Tirzepatide | 31 | $34K |
| Mirabegron | 28 | $23K |
| Rivaroxaban | 21 | $21K |
| Dapagliflozin Propanediol | 27 | $18K |
| Empagliflozin | 18 | $14K |
| Rosuvastatin Calcium | 692 | $13K |
| Dexlansoprazole | 30 | $12K |
| Insulin Aspart | 11 | $9,001 |
| Hydromorphone Hcl | 47 | $8,834 |
| Sitagliptin Phosphate | 32 | $8,751 |
| Atorvastatin Calcium | 496 | $6,601 |
| Mesalamine | 12 | $6,500 |
| Metoprolol Succinate | 288 | $6,483 |
Prescribing Profile
Patient Profile
76
Avg Age
45%
Female
1.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About